Accolade, Inc. (ACCD)

Market Cap	573.13M
Revenue (ttm)	446.72M
Net Income (ttm)	-180.30M
Shares Out	81.99M
EPS (ttm)	-2.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	353,157
Open	6.99
Previous Close	7.00
Day's Range	6.99 - 7.00
52-Week Range	3.08 - 10.45
Beta	2.19
Analysts	Hold
Price Target	6.22 (-11.02%)
Earnings Date	Apr 24, 2025

About ACCD

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management speci...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 2, 2020
• Employees: 2,400
• Stock Exchange: NASDAQ
• Ticker Symbol: ACCD
• Website: https://www.accolade.com

Financial Performance

In 2023, Accolade's revenue was $414.29 million, an increase of 14.09% compared to the previous year's $363.14 million. Losses were -$99.81 million, -78.29% less than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for ACCD stock is "Hold." The 12-month stock price forecast is $6.22, which is a decrease of -11.02% from the latest price.

Price Target

$6.22

(-11.02% downside)

Analyst Consensus: Hold